Email not displaying correctly? Click here to view it in your browser.
Therakos Mallinckrodt

Monday 27th March 2017 12:45 – 14:15

Hall 1, Palais des Congrès – Marseille Chanot

The information in this email is intended only for healthcare professionals in
Europe, the Middle East and Asia Pacific.

Therakos Integrated Photopheresis:
Value for Nurses and Patients through Education
Programme Chair: John Murray, Manchester, UK
12.45 – 12.55
Stem Cell Transplant (SCT) and the Treatment of GvHD is changing.
Where can ECP Fit in the Future?

Dr Andrew Gennery, Newcastle, UK
12.55 – 13.25
Vascular Access Workshop
a. Case Study 1 – Davina Potok, NHSBT, UK
b. Case Study 2 – Cherie Rushton, Rotherham, UK
c. LBW Case Study 3 – Julie Guest, Newcastle, UK
13.25 – 13.55
Setting Up an ECP Service – The Oslo Experience from Start to Finish to Future
Jørn Kristiansen, Oslo, Norway
13.55 – 14.05
JACIE Considerations for ECP Services
Carole Charley, JACIE Report Assessor
14.05 – 14.15
My Transplant Story – ECP and QOL
Chris Lewis, Patient Speaker
Therakos will be exhibiting at EBMT 2017. Come along to stand 17 to meet the team.

EBMT 2017

Learn more about Mallinckrodt Pharmaceuticals by visiting www.mallinckrodt.com
Mallinckrodt, the “M” brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company.
Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2017 Mallinckrodt.

Privacy policy   Legal notice
If you would prefer not to receive e-documents from us in the future please reply with the word 'Unsubscribe'